CHMP Recommends Approval of Lilly and Incyte’s OLUMIANT (baricitinib) as the First and Only Centrally-Authorized Treatment for Adults with Severe Alopecia Areata (AA) Read more
PURIFY’22 Takes Chromatography Purification Notches Higher; Industry Rallies Around this Mega Event Read more
Ascentage Pharma Announces Preclinical Data Demonstrating Olverembatinib’s Therapeutic Potential in Treating COVID-19 Published in EMBO Molecular Medicine Read more
Tonix Pharmaceuticals Extends Research Collaboration with the University of Alberta to Develop Antiviral Drugs Against SARS-CoV-2 Read more
PostEra spearheads AI-driven drug discovery collaboration to develop antiviral therapeutics with initial $68M in NIH funding Read more
SwanBio Therapeutics Announces $56 Million Series B Financing to Advance Novel Gene Therapies for Neurological Conditions Read more
AstraZeneca signs licence agreement with RQ Biotechnology for monoclonal antibodies against COVID-19 Read more
Pfizer and BioNTech Granted U.S. Emergency Use Authorization for Booster Dose of Their COVID-19 Vaccine in Children 5 Through 11 Years of Age Read more